Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marija Balic

Showing results (1-10 of 121) with videos related to

Pageof 13
Sort By:
Breast Care (Basel, Switzerland)|January 15, 2021
Understanding and Treating HER BetterMarija Balic
Biomarkers in Medicine|May 19, 2010
Disseminated tumor cells as biomarkers for breast cancerMarija Balic
Annals of Translational Medicine|December 14, 2020
It is time to prepare for D-CARE!Christoph Suppan, Marija Balic
Breast Care (Basel, Switzerland)|January 2, 2023
Evolution of HER2 Targeting in Metastatic Breast CancerRupert Bartsch, Marija Balic
Breast Care (Basel, Switzerland)|March 6, 2023
Current Standards and Future Outlooks in Metastatic Her2-Positive Breast CancerChristoph Suppan, Marija Balic
Memo|July 21, 2017
Early stage breast cancer treatment and prognostic factors: Post San Antonio Breast Cancer Symposium 2016Christoph Suppan, Marija Balic
Ebiomedicine|December 1, 2022
Deciphering the molecular landscape of metastatic lobular breast cancerNadia Dandachi, Marija Balic
International Journal of Molecular Sciences|July 18, 2013
The role of microRNAs in breast cancer stem cellsDaniela Schwarzenbacher, Marija Balic, Martin Pichler
Breast Care (Basel, Switzerland)|January 27, 2022
Position Paper on the Value of Extended Adjuvant Therapy with Neratinib for Early HER2+/HR+ Breast CancerMarija Balic, Gabriel Rinnerthaler, Rupert Bartsch
Seminars in Oncology|August 31, 2015
Circulating Tumor Cells: Where From Here?Ram H Datar, Marija Balic, Richard J Cote
Pageof 13

Showing results (1-10 of 121) with videos related to

Sort By:
Pageof 13
Breast Care (Basel, Switzerland)|January 15, 2021
Understanding and Treating HER BetterMarija Balic
Biomarkers in Medicine|May 19, 2010
Disseminated tumor cells as biomarkers for breast cancerMarija Balic
Annals of Translational Medicine|December 14, 2020
It is time to prepare for D-CARE!Christoph Suppan, Marija Balic
Breast Care (Basel, Switzerland)|January 2, 2023
Evolution of HER2 Targeting in Metastatic Breast CancerRupert Bartsch, Marija Balic
Breast Care (Basel, Switzerland)|March 6, 2023
Current Standards and Future Outlooks in Metastatic Her2-Positive Breast CancerChristoph Suppan, Marija Balic
Memo|July 21, 2017
Early stage breast cancer treatment and prognostic factors: Post San Antonio Breast Cancer Symposium 2016Christoph Suppan, Marija Balic
Ebiomedicine|December 1, 2022
Deciphering the molecular landscape of metastatic lobular breast cancerNadia Dandachi, Marija Balic
International Journal of Molecular Sciences|July 18, 2013
The role of microRNAs in breast cancer stem cellsDaniela Schwarzenbacher, Marija Balic, Martin Pichler
Breast Care (Basel, Switzerland)|January 27, 2022
Position Paper on the Value of Extended Adjuvant Therapy with Neratinib for Early HER2+/HR+ Breast CancerMarija Balic, Gabriel Rinnerthaler, Rupert Bartsch
Seminars in Oncology|August 31, 2015
Circulating Tumor Cells: Where From Here?Ram H Datar, Marija Balic, Richard J Cote
Pageof 13